Only ready-to-use liquid format of bivalirudin on the market Does not require reconstitution, dilution or mixing, which helps increase efficiency for hospitals and healthcare providers DUBLIN, July 18 ...
Mumbai: Global tenders floated by Maharashtra government seeking liquid oxygen, oxygen concentrators and anti-viral remdesivir injections have received responses and it is likely work orders will be ...
Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive ...
Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 ...
Hospitals are experiencing a national shortage of sterile water for injection vials, according to the American Society of Health-System Pharmacists. Here are five things to know about the shortage. 1.
Endo’s subsidiary Endo Ventures has reached an agreement with Maia Pharmaceuticals to distribute bivalirudin injection in a ready-to-use 250 mg/50 ml single-use vial in the United States. Endo will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback